‘Encouraging’ signal: GLP-1s may help reduce breast cancer recurrence, improve survival

GLP-1 receptor agonists may help improve outcomes among women with breast cancer and chronic cardiometabolic diseases, results of a retrospective cohort study suggest.Women with breast cancer and obesity who used GLP-1 medications exhibited significantly lower risks for all-cause mortality or recurrence than nonusers.